{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:19:48Z","timestamp":1793139588425,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1001\/jamaneurol.2020.1179","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T11:02:05Z","timestamp":1590490925000},"page":"1069","source":"Crossref","is-referenced-by-count":122,"title":["Comparison of 3 Treatment Strategies for Medication Overuse Headache"],"prefix":"10.1001","volume":"77","author":[{"given":"Louise Ninett","family":"Carlsen","sequence":"first","affiliation":[{"name":"Currently a PhD student at the University of Copenhagen, Copenhagen, Denmark"},{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Bruun","family":"Munksgaard","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Maria Storm","family":"Engelstoft","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lurenda","family":"Westergaard","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bendtsen","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigmor H\u00f8jland","family":"Jensen","sequence":"additional","affiliation":[{"name":"Danish Headache Center, Rigshospitalet, Glostrup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9995","key":"noi200027r1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"noi200027r2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/ene.2012.19.issue-5","article-title":"The cost of headache disorders in Europe: the Eurolight project.","volume":"19","author":"Linde","year":"2012","journal-title":"Eur J Neurol"},{"issue":"2","key":"noi200027r3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/0333102418786265","article-title":"Economic benefits of treating medication-overuse headache: results from the multicenter COMOESTAS project.","volume":"39","author":"Jellestad","year":"2019","journal-title":"Cephalalgia"},{"issue":"1","key":"noi200027r4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ene.v27.1","article-title":"The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient-derived data.","volume":"27","author":"Raggi","year":"2020","journal-title":"Eur J Neurol"},{"issue":"10053","key":"noi200027r5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"388","author":"Global","year":"2016","journal-title":"Lancet"},{"issue":"4 Headache","key":"noi200027r6","first-page":"1118","article-title":"Risk factors for and management of medication-overuse headache.","volume":"21","author":"Lipton","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"issue":"22","key":"noi200027r7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1212\/01.wnl.0000335946.53860.1d","article-title":"Excessive acute migraine medication use and migraine progression.","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"8","key":"noi200027r8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/hed.2008.48.issue-8","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study.","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"issue":"12","key":"noi200027r9","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1212\/WNL.0000000000004374","article-title":"Medication overuse headache: an ongoing debate.","volume":"89","author":"Louter","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"noi200027r10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, prevention, and treatment of medication overuse headache.","volume":"18","author":"Diener","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi200027r11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","article-title":"Treatment of medication overuse headache: guideline of the EFNS headache panel.","volume":"18","author":"Evers","year":"2011","journal-title":"Eur J Neurol"},{"issue":"9","key":"noi200027r12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0333102414521508","article-title":"A consensus protocol for the management of medication-overuse headache: evaluation in a multicentric, multinational study.","volume":"34","author":"Tassorelli","year":"2014","journal-title":"Cephalalgia"},{"issue":"2","key":"noi200027r13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0333102417737779","article-title":"Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial.","volume":"38","author":"Carlsen","year":"2018","journal-title":"Cephalalgia"},{"issue":"2","key":"noi200027r14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00415-015-7975-1","article-title":"Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial.","volume":"263","author":"Kristoffersen","year":"2016","journal-title":"J Neurol"},{"issue":"suppl 1","key":"noi200027r15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10194-011-0402-9","article-title":"Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012.","volume":"13","author":"Bendtsen","year":"2012","journal-title":"J Headache Pain"},{"issue":"6","key":"noi200027r16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10194-009-0159-6","article-title":"A narrative review on the management of medication overuse headache: the steep road from experience to evidence.","volume":"10","author":"Rossi","year":"2009","journal-title":"J Headache Pain"},{"issue":"2","key":"noi200027r17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/hed.2007.47.issue-2","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"issue":"1-2","key":"noi200027r18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.","volume":"331","author":"Silberstein","year":"2013","journal-title":"J Neurol Sci"},{"issue":"20","key":"noi200027r19","doi-asserted-by":"publisher","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","article-title":"Erenumab in chronic migraine with medication overuse: subgroup analysis of a randomized trial.","volume":"92","author":"Tepper","year":"2019","journal-title":"Neurology"},{"issue":"15","key":"noi200027r20","article-title":"The impact of fremanezumab on medication overuse in patients with chronic migraine (P1.10-026).","volume":"92","author":"Silberstein","year":"2019","journal-title":"Neurology"},{"issue":"12","key":"noi200027r23","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1212\/01.wnl.0000217914.30994.bd","article-title":"Probable medication-overuse headache: the effect of a 2-month drug-free period.","volume":"66","author":"Zeeberg","year":"2006","journal-title":"Neurology"},{"issue":"10","key":"noi200027r24","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1212\/01.WNL.0000063322.14078.90","article-title":"Rates and predictors for relapse in medication overuse headache: a 1-year prospective study.","volume":"60","author":"Katsarava","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"noi200027r25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","article-title":"Management of medication overuse headache: 1-year randomized multicentre open-label trial.","volume":"29","author":"Hagen","year":"2009","journal-title":"Cephalalgia"},{"issue":"6","key":"noi200027r26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0333102413515338","article-title":"Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment: results from a multicentre, multinational study (COMOESTAS project).","volume":"34","author":"Bendtsen","year":"2014","journal-title":"Cephalalgia"},{"issue":"7","key":"noi200027r27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"issue":"5","key":"noi200027r28","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/brain\/awz052","article-title":"Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.","volume":"142","author":"Pijpers","year":"2019","journal-title":"Brain"},{"issue":"2","key":"noi200027r29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.pain.2010.07.032","article-title":"Prevention of medication overuse in patients with migraine.","volume":"151","author":"Fritsche","year":"2010","journal-title":"Pain"},{"key":"noi200027r30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1129-2377-14-10","article-title":"Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial.","volume":"14","author":"Rossi","year":"2013","journal-title":"J Headache Pain"},{"issue":"7","key":"noi200027r31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1177\/0333102417736898","article-title":"National awareness campaign to prevent medication-overuse headache in Denmark.","volume":"38","author":"Carlsen","year":"2018","journal-title":"Cephalalgia"},{"issue":"15","key":"noi200027r32","article-title":"Demographics, headache characteristics, and other factors associated with opioid use in people with migraine: results from the CaMEO Study (S59.006).","volume":"92","author":"Lipton","year":"2019","journal-title":"Neurology"},{"key":"noi200027r21","author":"The International Classification of Headache Disorders,","year":"2013"},{"key":"noi200027r22","unstructured":"Sealed Envelope: randomisation and online databases for clinical trials. Date. Accessed April 23, 2020. https:\/\/www.sealedenvelope.com\/"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2766518\/jamaneurology_carlsen_2020_oi_200027_1598965158.57228.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:02:48Z","timestamp":1600081368000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2766518"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2020.1179","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738024498.793575312","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}